Clearside Biomedical (CLSD) Misses Q1 EPS by 1c

Clearside Biomedical (NASDAQ: CLSD) reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $4 million versus the consensus estimate of $154 thousand.

For earnings history and earnings-related data on Clearside Biomedical (CLSD) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
• The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does